Samuel Herschkowitz is the Chief Executive Officer at Serenity Pharmaceuticals, a role held until 2022, where they led clinical activities and fundraising efforts. They currently serve as Vice Chairman of the Board at Acerus Pharma and hold multiple positions at Delcath Systems, Inc, including Chairman and Chief Operating Officer. Additionally, they have been an Entrepreneur at NYU School of Medicine since 1982 and previously directed the NYU Psychoanalytic Institute. Samuel earned their Doctor of Medicine degree from SUNY Downstate Medical Center between 1971 and 1975.
This person is not in the org chart
This person is not in any teams
This person is not in any offices